A Multicenter Randomized Double-Blinded Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease



Study Overview

The purpose of this research study is to investigate the safety and how well inhaled treprostinil works in subjects with pulmonary hypertension (PH) associated with interstitial lung disease (ILD) or combined pulmonary fibrosis and emphysema (CPFE).


Study Description

The purpose of this study is to investigate the safety and how well inhaled treprostinil works in subjects with WHO Group 3 PH.

Additional Information:

Participants will be paid for their participation.



Research Study Identifier: TX6365
ClinicalTrials.gov Identifier: NCT1602009422
Principal Investigator: William L F Harvey, MD


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.